APO Research
Talk to an analyst

APO RESEARCH · REPORT

Children Influenza Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Children Influenza Vaccine Industry Research Report 2026

29 December 2025129 pages

Choose your research edition.

Industry ResearchChildren Influenza Vaccine Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Children Influenza Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Children Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Children Influenza Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Children Influenza Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Children Influenza Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Children Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Children Influenza Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Children Influenza Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Children Influenza Vaccine include BCHT, CCBIO, CSL, Hulan Bio, KM Biologics, Sanofi Pasteur, Sinovac, Viatris and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Children Influenza Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Children Influenza Vaccine Market by Company

BCHT

CCBIO

CSL

Hulan Bio

KM Biologics

Sanofi Pasteur

Sinovac

Viatris

AstraZeneca

GSK

Jiangsu GDK

Children Influenza Vaccine Segment by Type

Nasal Spray

Injection

Children Influenza Vaccine Segment by Application

Public

Private

Children Influenza Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Children Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Children Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Children Influenza Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Children Influenza Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Children Influenza Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Children Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Children Influenza Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Children Influenza Vaccine Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Children Influenza Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Children Influenza Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global Children Influenza Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Children Influenza Vaccine Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Children Influenza Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Children Influenza Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Children Influenza Vaccine, Product Type & Application Table 14. Global Children Influenza Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Children Influenza Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. BCHT Company Information Table 19. BCHT Business Overview Table 20. BCHT Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. BCHT Children Influenza Vaccine Product Portfolio Table 22. BCHT Recent Developments Table 23. CCBIO Company Information Table 24. CCBIO Business Overview Table 25. CCBIO Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. CCBIO Children Influenza Vaccine Product Portfolio Table 27. CCBIO Recent Developments Table 28. CSL Company Information Table 29. CSL Business Overview Table 30. CSL Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. CSL Children Influenza Vaccine Product Portfolio Table 32. CSL Recent Developments Table 33. Hulan Bio Company Information Table 34. Hulan Bio Business Overview Table 35. Hulan Bio Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Hulan Bio Children Influenza Vaccine Product Portfolio Table 37. Hulan Bio Recent Developments Table 38. KM Biologics Company Information Table 39. KM Biologics Business Overview Table 40. KM Biologics Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. KM Biologics Children Influenza Vaccine Product Portfolio Table 42. KM Biologics Recent Developments Table 43. Sanofi Pasteur Company Information Table 44. Sanofi Pasteur Business Overview Table 45. Sanofi Pasteur Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Sanofi Pasteur Children Influenza Vaccine Product Portfolio Table 47. Sanofi Pasteur Recent Developments Table 48. Sinovac Company Information Table 49. Sinovac Business Overview Table 50. Sinovac Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Sinovac Children Influenza Vaccine Product Portfolio Table 52. Sinovac Recent Developments Table 53. Viatris Company Information Table 54. Viatris Business Overview Table 55. Viatris Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Viatris Children Influenza Vaccine Product Portfolio Table 57. Viatris Recent Developments Table 58. AstraZeneca Company Information Table 59. AstraZeneca Business Overview Table 60. AstraZeneca Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. AstraZeneca Children Influenza Vaccine Product Portfolio Table 62. AstraZeneca Recent Developments Table 63. GSK Company Information Table 64. GSK Business Overview Table 65. GSK Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. GSK Children Influenza Vaccine Product Portfolio Table 67. GSK Recent Developments Table 68. Jiangsu GDK Company Information Table 69. Jiangsu GDK Business Overview Table 70. Jiangsu GDK Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Jiangsu GDK Children Influenza Vaccine Product Portfolio Table 72. Jiangsu GDK Recent Developments Table 73. Global Children Influenza Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 74. Global Children Influenza Vaccine Sales by Region (2021-2026) & (K Units) Table 75. Global Children Influenza Vaccine Sales Market Share by Region (2021-2026) Table 76. Global Children Influenza Vaccine Sales by Region (2027-2032) & (K Units) Table 77. Global Children Influenza Vaccine Sales Market Share by Region (2027-2032) Table 78. Global Children Influenza Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 79. Global Children Influenza Vaccine Revenue Market Share by Region (2021-2026) Table 80. Global Children Influenza Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 81. Global Children Influenza Vaccine Revenue Market Share by Region (2027-2032) Table 82. North America Children Influenza Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. North America Children Influenza Vaccine Sales by Country (2021-2026) & (K Units) Table 84. North America Children Influenza Vaccine Sales by Country (2027-2032) & (K Units) Table 85. North America Children Influenza Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Children Influenza Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 87. Europe Children Influenza Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Europe Children Influenza Vaccine Sales by Country (2021-2026) & (K Units) Table 89. Europe Children Influenza Vaccine Sales by Country (2027-2032) & (K Units) Table 90. Europe Children Influenza Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 91. Europe Children Influenza Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 92. Asia Pacific Children Influenza Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Asia Pacific Children Influenza Vaccine Sales by Country (2021-2026) & (K Units) Table 94. Asia Pacific Children Influenza Vaccine Sales by Country (2027-2032) & (K Units) Table 95. Asia Pacific Children Influenza Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 96. Asia Pacific Children Influenza Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 97. South America Children Influenza Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. South America Children Influenza Vaccine Sales by Country (2021-2026) & (K Units) Table 99. South America Children Influenza Vaccine Sales by Country (2027-2032) & (K Units) Table 100. South America Children Influenza Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 101. South America Children Influenza Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 102. Middle East and Africa Children Influenza Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Middle East and Africa Children Influenza Vaccine Sales by Country (2021-2026) & (K Units) Table 104. Middle East and Africa Children Influenza Vaccine Sales by Country (2027-2032) & (K Units) Table 105. Middle East and Africa Children Influenza Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 106. Middle East and Africa Children Influenza Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 107. Global Children Influenza Vaccine Sales by Type (2021-2026) & (K Units) Table 108. Global Children Influenza Vaccine Sales by Type (2027-2032) & (K Units) Table 109. Global Children Influenza Vaccine Sales Market Share by Type (2021-2026) Table 110. Global Children Influenza Vaccine Sales Market Share by Type (2027-2032) Table 111. Global Children Influenza Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 112. Global Children Influenza Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 113. Global Children Influenza Vaccine Revenue Market Share by Type (2021-2026) Table 114. Global Children Influenza Vaccine Revenue Market Share by Type (2027-2032) Table 115. Global Children Influenza Vaccine Price by Type (2021-2026) & (US$/Unit) Table 116. Global Children Influenza Vaccine Price by Type (2027-2032) & (US$/Unit) Table 117. Global Children Influenza Vaccine Sales by Application (2021-2026) & (K Units) Table 118. Global Children Influenza Vaccine Sales by Application (2027-2032) & (K Units) Table 119. Global Children Influenza Vaccine Sales Market Share by Application (2021-2026) Table 120. Global Children Influenza Vaccine Sales Market Share by Application (2027-2032) Table 121. Global Children Influenza Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 122. Global Children Influenza Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 123. Global Children Influenza Vaccine Revenue Market Share by Application (2021-2026) Table 124. Global Children Influenza Vaccine Revenue Market Share by Application (2027-2032) Table 125. Global Children Influenza Vaccine Price by Application (2021-2026) & (US$/Unit) Table 126. Global Children Influenza Vaccine Price by Application (2027-2032) & (US$/Unit) Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Children Influenza Vaccine Distributors List Table 130. Children Influenza Vaccine Customers List Table 131. Children Influenza Vaccine Industry Trends Table 132. Children Influenza Vaccine Industry Drivers Table 133. Children Influenza Vaccine Industry Restraints Table 134. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Children Influenza Vaccine Product Image Figure 5. Global Children Influenza Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Children Influenza Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global Children Influenza Vaccine Sales (2021-2032) & (K Units) Figure 8. Global Children Influenza Vaccine Average Price (US$/Unit) & (2021-2032) Figure 9. Nasal Spray Product Image Figure 10. Injection Product Image Figure 11. Public Product Image Figure 12. Private Product Image Figure 13. Global Children Influenza Vaccine Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Children Influenza Vaccine, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Children Influenza Vaccine Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Children Influenza Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Children Influenza Vaccine Sales by Region in 2025 Figure 19. Global Children Influenza Vaccine Revenue by Region in 2025 Figure 20. North America Children Influenza Vaccine Market Size by Country in 2025 Figure 21. North America Children Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 22. North America Children Influenza Vaccine Revenue Market Share by Country (2021-2032) Figure 23. United States Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Europe Children Influenza Vaccine Market Size by Country in 2025 Figure 26. Europe Children Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 27. Europe Children Influenza Vaccine Revenue Market Share by Country (2021-2032) Figure 28. Germany Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. France Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. U.K. Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Italy Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Netherlands Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Asia Pacific Children Influenza Vaccine Market Size by Country in 2025 Figure 34. Asia Pacific Children Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 35. Asia Pacific Children Influenza Vaccine Revenue Market Share by Country (2021-2032) Figure 36. China Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Japan Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. South Korea Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. India Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Australia Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. China Taiwan Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Southeast Asia Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South America Children Influenza Vaccine Market Size by Country in 2025 Figure 45. South America Children Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 46. South America Children Influenza Vaccine Revenue Market Share by Country (2021-2032) Figure 47. Mexico Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Brazil Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Argentina Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Colombia Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Middle East and Africa Children Influenza Vaccine Market Size by Country in 2025 Figure 52. Middle East and Africa Children Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 53. Middle East and Africa Children Influenza Vaccine Revenue Market Share by Country (2021-2032) Figure 54. Turkey Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Saudi Arabia Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. UAE Children Influenza Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Global Children Influenza Vaccine Sales Market Share by Type (2021-2032) Figure 58. Global Children Influenza Vaccine Revenue Market Share by Type (2021-2032) Figure 59. Global Children Influenza Vaccine Price (US$/Unit) by Type (2021-2032) Figure 60. Global Children Influenza Vaccine Sales Market Share by Application (2021-2032) Figure 61. Global Children Influenza Vaccine Revenue Market Share by Application (2021-2032) Figure 62. Global Children Influenza Vaccine Price (US$/Unit) by Application (2021-2032) Figure 63. Children Influenza Vaccine Value Chain Figure 64. Children Influenza Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Children Influenza Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Nasal Spray
  • Injection
Applications
  • Public
  • Private
Companies covered
  • BCHT
  • CCBIO
  • CSL
  • Hulan Bio
  • KM Biologics
  • Sanofi Pasteur
  • Sinovac
  • Viatris
  • AstraZeneca
  • GSK
  • Jiangsu GDK

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Children Influenza Vaccine Market Size (2021-2032)
  4. 2.2.2 Global Children Influenza Vaccine Sales (2021-2032)
  5. 2.2.3 Global Children Influenza Vaccine Market Average Price (2021-2032)
  6. 2.3 Children Influenza Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Nasal Spray
  9. 2.3.3 Injection
  10. 2.4 Children Influenza Vaccine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Public
  13. 2.4.3 Private
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Children Influenza Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Children Influenza Vaccine Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Children Influenza Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Children Influenza Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Children Influenza Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Children Influenza Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Children Influenza Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of Children Influenza Vaccine, Established Date
  9. 3.9 Global Children Influenza Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 BCHT
  2. 4.1.1 BCHT Company Information
  3. 4.1.2 BCHT Business Overview
  4. 4.1.3 BCHT Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 BCHT Children Influenza Vaccine Product Portfolio
  6. 4.1.5 BCHT Recent Developments
  7. 4.2 CCBIO
  8. 4.2.1 CCBIO Company Information
  9. 4.2.2 CCBIO Business Overview
  10. 4.2.3 CCBIO Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 CCBIO Children Influenza Vaccine Product Portfolio
  12. 4.2.5 CCBIO Recent Developments
  13. 4.3 CSL
  14. 4.3.1 CSL Company Information
  15. 4.3.2 CSL Business Overview
  16. 4.3.3 CSL Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 CSL Children Influenza Vaccine Product Portfolio
  18. 4.3.5 CSL Recent Developments
  19. 4.4 Hulan Bio
  20. 4.4.1 Hulan Bio Company Information
  21. 4.4.2 Hulan Bio Business Overview
  22. 4.4.3 Hulan Bio Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Hulan Bio Children Influenza Vaccine Product Portfolio
  24. 4.4.5 Hulan Bio Recent Developments
  25. 4.5 KM Biologics
  26. 4.5.1 KM Biologics Company Information
  27. 4.5.2 KM Biologics Business Overview
  28. 4.5.3 KM Biologics Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 KM Biologics Children Influenza Vaccine Product Portfolio
  30. 4.5.5 KM Biologics Recent Developments
  31. 4.6 Sanofi Pasteur
  32. 4.6.1 Sanofi Pasteur Company Information
  33. 4.6.2 Sanofi Pasteur Business Overview
  34. 4.6.3 Sanofi Pasteur Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Sanofi Pasteur Children Influenza Vaccine Product Portfolio
  36. 4.6.5 Sanofi Pasteur Recent Developments
  37. 4.7 Sinovac
  38. 4.7.1 Sinovac Company Information
  39. 4.7.2 Sinovac Business Overview
  40. 4.7.3 Sinovac Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Sinovac Children Influenza Vaccine Product Portfolio
  42. 4.7.5 Sinovac Recent Developments
  43. 4.8 Viatris
  44. 4.8.1 Viatris Company Information
  45. 4.8.2 Viatris Business Overview
  46. 4.8.3 Viatris Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Viatris Children Influenza Vaccine Product Portfolio
  48. 4.8.5 Viatris Recent Developments
  49. 4.9 AstraZeneca
  50. 4.9.1 AstraZeneca Company Information
  51. 4.9.2 AstraZeneca Business Overview
  52. 4.9.3 AstraZeneca Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 AstraZeneca Children Influenza Vaccine Product Portfolio
  54. 4.9.5 AstraZeneca Recent Developments
  55. 4.10 GSK
  56. 4.10.1 GSK Company Information
  57. 4.10.2 GSK Business Overview
  58. 4.10.3 GSK Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 GSK Children Influenza Vaccine Product Portfolio
  60. 4.10.5 GSK Recent Developments
  61. 4.11 Jiangsu GDK
  62. 4.11.1 Jiangsu GDK Company Information
  63. 4.11.2 Jiangsu GDK Business Overview
  64. 4.11.3 Jiangsu GDK Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Jiangsu GDK Children Influenza Vaccine Product Portfolio
  66. 4.11.5 Jiangsu GDK Recent Developments
5 Global Children Influenza Vaccine Market Scenario by Region
  1. 5.1 Global Children Influenza Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Children Influenza Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global Children Influenza Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global Children Influenza Vaccine Sales by Region: 2027-2032
  5. 5.3 Global Children Influenza Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global Children Influenza Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global Children Influenza Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America Children Influenza Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America Children Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Children Influenza Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America Children Influenza Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Children Influenza Vaccine Market Facts & Figures by Country
  15. 5.5.1 Europe Children Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Children Influenza Vaccine Sales by Country (2021-2032)
  17. 5.5.3 Europe Children Influenza Vaccine Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Children Influenza Vaccine Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Children Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Children Influenza Vaccine Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Children Influenza Vaccine Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Children Influenza Vaccine Market Facts & Figures by Country
  35. 5.7.1 South America Children Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Children Influenza Vaccine Sales by Country (2021-2032)
  37. 5.7.3 South America Children Influenza Vaccine Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.7.7 Colombia
  42. 5.8 Middle East and Africa Children Influenza Vaccine Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Children Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Children Influenza Vaccine Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Children Influenza Vaccine Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Children Influenza Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global Children Influenza Vaccine Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Children Influenza Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Children Influenza Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global Children Influenza Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Children Influenza Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Children Influenza Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Children Influenza Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global Children Influenza Vaccine Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Children Influenza Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Children Influenza Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global Children Influenza Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Children Influenza Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Children Influenza Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Children Influenza Vaccine Value Chain Analysis
  2. 8.1.1 Children Influenza Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Children Influenza Vaccine Production Mode & Process
  5. 8.2 Children Influenza Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Children Influenza Vaccine Distributors
  8. 8.2.3 Children Influenza Vaccine Customers
9 Global Children Influenza Vaccine Analyzing Market Dynamics
  1. 9.1 Children Influenza Vaccine Industry Trends
  2. 9.2 Children Influenza Vaccine Industry Drivers
  3. 9.3 Children Influenza Vaccine Industry Opportunities and Challenges
  4. 9.4 Children Influenza Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst